Stephanie Greene
Out Team
Dr. Greene, Vice President of Clinical Pharmacology and Toxicology
(Co-founder)
Dr. Greene received her Ph.D. from the University of California at Davis and conducted a NIH postdoctoral fellowship at the University of California medical school. She worked as a toxicologist and safety expert on the metabolic disorders and CV licensing teams at Amgen, and was the toxicologist on the first eCTD at Amgen for Sensipar™.
She was the nonclinical lead for Afrezza® inhaled insulin and cancer immunotherapy at MannKind Corp and the department head for pharmacology and toxicology. Dr Greene cofounded Orinove Inc and has supported the ongoing clinical trials with ORIN1001.
